Credit Acceptance Corporation filings document the regulatory record for a Nasdaq-listed consumer finance company with common stock registered under the ticker CACC. Its disclosures cover operating results, non-GAAP adjusted income measures, loan portfolio performance, forecasted future collections, dealer holdback payments, and risks tied to the automobile finance market and non-prime consumer credit.
The company's SEC filings also include material-event reports on asset-backed non-recourse secured financings, amendments to loan and security agreements, and trust or special purpose entity structures used to convey consumer loans and issue notes. Proxy materials document board matters, executive compensation, incentive plan information, shareholder voting items, and governance practices, while 8-K filings record officer transitions, Regulation FD materials, and other capital-structure or financing events.
Credit Acceptance Corp (CACC) Chief Marketing and Product Officer Andrew K. Rostami reported insider trading activity on June 20, 2025. The executive sold 375 shares at $505.29 per share, resulting in a transaction value of approximately $189,484.
Following the transaction, Rostami holds 25,478.5 shares, including 23,572 unvested restricted stock units granted under the Company's Incentive Compensation Plan. Additionally, the executive maintains 16,000 stock options with an exercise price of $585.93, which vest in four equal annual installments starting April 18, 2023 and expire on April 18, 2028.
This Form 4 filing indicates a relatively small disposition of shares by a senior executive while maintaining a substantial equity position in the company through direct ownership, RSUs, and options, suggesting continued alignment with shareholder interests.
Credit Acceptance Corp (NASDAQ: CACC) has filed a Form 144 notice for a proposed sale of securities by an insider. The filing details plans to sell 375 shares of common stock with an aggregate market value of $189,483.75, representing a small portion of the total 11,603,475 shares outstanding.
The shares to be sold were acquired through two restricted stock vesting events:
- 90 shares vested on October 31, 2023
- 285 shares vested on April 18, 2024
The planned sale is scheduled for June 20, 2025 through Fidelity Brokerage Services. The securities were originally acquired as compensation through restricted stock vesting. The filing indicates no other sales by the insider in the past 3 months, suggesting this is an isolated transaction rather than part of a larger selling pattern.